SCHEMBL29856503

SCHEMBL29856503

Cc1c(C(=O)c2ccc(O)cc2)c2ccncc2n1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 1/20 0.44
ADORA2A P29274 1/20 0.44
ROCK2 O75116 6/20 0.40
MAPT P10636 3/20 0.39
HTT P42858 3/20 0.39
HPGD P15428 2/20 0.39
ESR1 P03372 1/20 0.39
ESR2 Q92731 1/20 0.39
LMNA P02545 1/20 0.39
PKM P14618 1/20 0.39
CYP2C19 P33261 1/20 0.38
EYA3 Q99504 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
KDM4E B2RXH2 1/20 0.37
NPC1 O15118 1/20 0.37
TP53 P04637 1/20 0.37
RAB9A P51151 1/20 0.37
ATM Q13315 1/20 0.36
USP14 P54578 1/20 0.36
CYP19A1 P11511 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29856230 0.84 ROCK2 (0.42) ADORA3ADORA2AROCK2MAPTHTT
SCHEMBL29856340 0.84 ROCK2 (0.38) ADORA3ADORA2AROCK2MAPTHTT
SCHEMBL29856214 0.84 KDM5A (0.40) ADORA3ADORA2AROCK2MAPTHTT
SCHEMBL29856274 0.82 ROCK2 (0.36) ADORA3ADORA2AROCK2MAPTHTT
SCHEMBL29856228 0.81 ADORA3 (0.46) ADORA3ADORA2AROCK2MAPTHTT
SCHEMBL1288011 0.79 SRC (0.55) MAPTHTTHPGDLMNACYP2C19
SCHEMBL25942232 0.76 ALDH1A1 (0.51) MAPTHPGDLMNAPKMCYP2C19
SCHEMBL29856145 0.76 POLB (0.51) MAPTHTTHPGDESR1ESR2
SCHEMBL29856192 0.75 KDM5A (0.50) ROCK2MAPTHTTEYA3CYP19A1
SCHEMBL29856217 0.73 TUBB4A (0.41) MAPTHTTHPGDESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022169974-A1 INHIBITORS OF URAT1 AND PHARMACEUTICAL USES THEREOF NEXYS THERAPEUTICS, INC. (US) 2022-08-11 WO disclosed